STOCK TITAN

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

NEXGEL (NASDAQ: NXGL), a provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 24, 2025, after market close.

The company will host a conference call at 4:30 P.M. ET on the same day. Interested participants can join via phone at 1-800-245-3047 (U.S. Toll Free) or 1-203-518-9765 (International). A replay will be available through April 3, 2025, accessible at 1-844-512-3921 (U.S.) or 1-412-317-6671 (International) using code 11158402. A webcast replay will be available for 90 days.

NEXGEL (NASDAQ: NXGL), fornitore di prodotti idrogel ultra-delicati e ad alta percentuale di acqua per applicazioni sanitarie e di consumo, ha programmato l'annuncio dei risultati finanziari del Quarto Trimestre e dell'Anno Completo 2024 per 24 marzo 2025, dopo la chiusura del mercato.

L'azienda ospiterà una conferenza telefonica alle 16:30 ET lo stesso giorno. I partecipanti interessati possono unirsi telefonicamente al numero 1-800-245-3047 (numero verde USA) o 1-203-518-9765 (internazionale). Una registrazione sarà disponibile fino al 3 aprile 2025, accessibile al numero 1-844-512-3921 (USA) o 1-412-317-6671 (internazionale) utilizzando il codice 11158402. Una registrazione del webcast sarà disponibile per 90 giorni.

NEXGEL (NASDAQ: NXGL), proveedor de productos de hidrogel ultra-suaves y de alto contenido en agua para aplicaciones de salud y consumo, ha programado el anuncio de sus resultados financieros del Cuarto Trimestre y del Año Completo 2024 para el 24 de marzo de 2025, después del cierre del mercado.

La empresa llevará a cabo una conferencia telefónica a las 4:30 P.M. ET el mismo día. Los participantes interesados pueden unirse por teléfono al 1-800-245-3047 (número gratuito en EE. UU.) o al 1-203-518-9765 (internacional). Una grabación estará disponible hasta el 3 de abril de 2025, accesible al 1-844-512-3921 (EE. UU.) o al 1-412-317-6671 (internacional) utilizando el código 11158402. Una repetición del webcast estará disponible durante 90 días.

NEXGEL (NASDAQ: NXGL)은 의료 및 소비자 응용 프로그램을 위한 초부드럽고 고수분 함량의 하이드로겔 제품 제공업체로, 2024년 4분기 및 전체 연도 재무 결과 발표를 2025년 3월 24일에 시장 종료 후로 예정했습니다.

회사는 같은 날 오후 4시 30분 ET에 전화 회의를 개최합니다. 관심 있는 참가자는 1-800-245-3047 (미국 무료전화) 또는 1-203-518-9765 (국제전화)로 전화에 참여할 수 있습니다. 2025년 4월 3일까지 이용 가능한 재생이 있으며, 1-844-512-3921 (미국) 또는 1-412-317-6671 (국제전화)로 접속할 수 있으며, 코드 11158402를 사용해야 합니다. 웹캐스트 재생은 90일 동안 제공됩니다.

NEXGEL (NASDAQ: NXGL), fournisseur de produits hydrogel ultra-doux et à forte teneur en eau pour les applications de santé et de consommation, a prévu l'annonce de ses résultats financiers pour le quatrième trimestre et l'année complète 2024 pour le 24 mars 2025, après la fermeture du marché.

La société animera une conférence téléphonique à 16h30 ET le même jour. Les participants intéressés peuvent rejoindre par téléphone au 1-800-245-3047 (numéro gratuit aux États-Unis) ou au 1-203-518-9765 (international). Un enregistrement sera disponible jusqu'au 3 avril 2025, accessible au 1-844-512-3921 (États-Unis) ou au 1-412-317-6671 (international) en utilisant le code 11158402. Un enregistrement du webinaire sera disponible pendant 90 jours.

NEXGEL (NASDAQ: NXGL), Anbieter von ultra-sanften Hydrogelprodukten mit hohem Wassergehalt für Gesundheits- und Verbraucheranwendungen, hat die Bekanntgabe seiner finanziellen Ergebnisse für das 4. Quartal und das Gesamtjahr 2024 für den 24. März 2025 nach Börsenschluss angesetzt.

Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz veranstalten. Interessierte Teilnehmer können sich telefonisch unter 1-800-245-3047 (US-Hotline) oder 1-203-518-9765 (international) einwählen. Eine Wiederholung wird bis zum 3. April 2025 verfügbar sein, erreichbar unter 1-844-512-3921 (USA) oder 1-412-317-6671 (international) mit dem Code 11158402. Eine Aufzeichnung des Webcasts wird 90 Tage lang verfügbar sein.

Positive
  • None.
Negative
  • None.

Management will host a conference call at 4:30 p.m. ET on the same day

LANGHORNE, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the fourth quarter and full year ended December 31, 2024, after the market closes on March 24, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

Fourth Quarter and Full Year 2024 Financial Results Conference Call
Date: March 24, 2025
Time: 4:30 p.m. ET
Live Call: 1-800-245-3047 (U.S. Toll Free) or 1-203-518-9765 (International)
Webcast: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through April 3, 2025 by dialing 1-844-512-2921(U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11158402. An archive of the webcast will also be available for 90 days.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com


FAQ

When will NEXGEL (NXGL) release its Q4 and Full Year 2024 earnings?

NEXGEL will release its Q4 and Full Year 2024 earnings on March 24, 2025, after market close.

How can investors join NXGL's Q4 2024 earnings call?

Investors can join via phone at 1-800-245-3047 (U.S.) or 1-203-518-9765 (International) at 4:30 P.M. ET on March 24, 2025.

How long will NXGL's Q4 2024 earnings webcast be available?

The webcast replay will be available for 90 days following the earnings call.

What is the replay information for NXGL's Q4 2024 earnings call?

Call replay available until April 3, 2025 at 1-844-512-3921 (U.S.) or 1-412-317-6671 (International), code: 11158402.
Nexgel Inc

NASDAQ:NXGL

NXGL Rankings

NXGL Latest News

NXGL Stock Data

19.93M
6.11M
20.56%
6.19%
1.52%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE